Patient access is not a post-approval task. Access is a development and launch input.
About us
Formed by the merger of PharmaCord and Mercalis, Valeris™ revolutionizes the path from life sciences innovation to real-life impact to build a world in which every patient gets the care they need to thrive. Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.
- Website
-
https://www.valeris.com
External link for Valeris
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Type
- Privately Held
Employees at Valeris
Updates
-
Next week, Jack M. and Mark Connors will be representing our team at inSPire 2026, joining leaders from across the specialty pharmacy community to exchange perspectives, explore emerging ideas and connect around the opportunities shaping the industry. If you’ll be attending inSPire, please reach out to our team to connect. #inSPire2026
-
-
Growth in life sciences requires more than a strong strategy. It takes the commercial experience to turn opportunity into execution and ultimately create greater impact for patients. Today, Valeris announced the appointment of Jeff Crowther as Chief Revenue Officer. Jeff brings more than 30 years of commercial leadership experience and a proven track record of building teams, launching therapies and driving growth across complex markets. His leadership will strengthen how Valeris connects strategy and execution as we continue to grow, innovate and deliver greater value for the organizations and patients we support. Join us in welcoming Jeff to Valeris and read the full announcement below.
-
-
In patient access, the expectation never changes. Complexity does. The question is not whether experience matters. It is whether we can see the moments where it is actually formed. Register now to join us next Thursday, August 27 for a live webinar with Chip Kennedy, Jack M., and Ivonne Ortiz. Together, they'll explore how operational intelligence can improve execution in real-time, ultimately supporting stronger patient outcomes.
-
-
Our team is excited to attend the Hub & Specialty Pharmacy Models West Conference. Our team is participating in two sessions focused on what’s next in patient access. We’ll explore how real-time intelligence can strengthen patient support, and why greater visibility into AI activity is critical. If you’ll be in San Diego, join us for one of our sessions and stop by the Valeris booth to connect with our team. Chip Kennedy, Jack M., Wallace Wolford, Stephanie Chesebro Informa Connect
-
Patient access is shaped by the decisions made long before a patient ever needs support. Today, Valeris announced the appointment of Lauren Cole as Chief Strategy Officer. In this role, Lauren will further connect commercial strategy, market access and patient services around the needs of patients. Her leadership will continue to shape how we anticipate barriers, design support and create a more connected path to therapy. Join us in welcoming Lauren to Valeris and read the full announcement below.
-
-
The promise of AI in patient access is ultimately measured by what it makes possible for patients. Adam Miller's appointment as Chief Technology and AI Officer reflects Valeris' continued focus on using technology, data, and AI to make the patient journey more connected, responsive, and informed. As Adam advances this work across Valeris, the focus remains clear: applying intelligence in ways that strengthen the decisions and interactions that shape a patient's path to therapy. Swipe to see the philosophy behind that approach.
-
Valeris is advancing its AI strategy with a clear focus: putting intelligence to work for patients. Today, Valeris announced the appointment of Adam Miller as Chief Technology and AI Officer. In this role, Adam will lead efforts to thoughtfully integrate AI and automation across the organization, strengthen data and analytics, and advance technology to enable better, faster, and more connected patient access. Join us in welcoming Adam to our team and read the full announcement linked below.
-
-
Valeris reposted this
From Valeris: 𝗔 𝗦𝘆𝘀𝘁𝗲𝗺 𝗼𝗳 𝗥𝗲𝗰𝗼𝗿𝗱, 𝗼𝗿 𝗮 𝗦𝘆𝘀𝘁𝗲𝗺 𝗼𝗳 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴? Download the white paper 👉 The Unified Ecosystem: How Valeris Integrates Intelligence and Execution for Better Patient Outcomes https://drugch.nl/4pZsKK2 Read the article: https://drugch.nl/3RRtfsW #sponsored
-
-
Our team is looking forward to attending the NACDS Total Store Expo in Boston! Reach out to schedule time to connect with us, or visit our team at Booth 1500. We look forward to seeing you there! Chris Mendez, Mark Connors National Association of Chain Drug Stores (NACDS)
-